Clinical trial
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008…
NCT00421707 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00421707 |
|---|---|
| Title | Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome |
| Official title | A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008 |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome (IBS) |
| Intervention type | Drug, Other |
| Interventions | GW876008, Placebo |
| Enrollment | 133 |
| Start date | Oct 14, 2006 |
| Primary completion | Jun 25, 2008 |
| Completion | Jun 25, 2008 |
| First posted | Jan 12, 2007 |
| Last update posted | Jan 31, 2018 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: